4.8 Article

Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice

期刊

JOURNAL OF HEPATOLOGY
卷 61, 期 6, 页码 1260-1266

出版社

ELSEVIER
DOI: 10.1016/j.jhep.2014.07.015

关键词

Sonic hedgehog; Acute liver failure; Azoxymethane; SMAD3; TGF beta 1; Hepatic encephalopathy

资金

  1. National Health and Medical Research Council of Australia
  2. Schizophrenia Research Institute
  3. National Institute of Alcohol Abuse and Alcoholism [NIH R24AA012725]
  4. Sydney Local Health Network Ethics Review Committee [X011-0107]

向作者/读者索取更多资源

Background & Aims: Hepatic encephalopathy (HE) is a neurologic disorder that develops during liver failure. Few studies exist investigating systemic-central signalling during HE outside of inflammatory signalling. The transcription factor Gli1, which can be modulated by hedgehog signalling or transforming growth factor beta 1 (TGF beta 1) signalling, has been shown to be protective in various neuropathies. We measured Gli1 expression in brain tissues from mice and evaluated how circulating TGF beta 1 and canonical hedgehog signalling regulate its activation. Methods: Mice were injected with azoxymethane(AOM) to induce liver failure and HE in the presence of Gli1 vivo-morpholinos, the hedgehog inhibitor cyclopamine, Smoothened vivo-morpholinos, a Smoothened agonist, or TGF beta-neutralizing antibodies. Molecular analyses were used to assess Gli1, hedgehog signalling, and TGF beta 1 signalling in the liver and brain of AOM mice and HE patients. Results: Gli1 expression was increased in brains of AOM mice and in HE patients. Intra-cortical infusion of Gli1 vivo-morpholinos exacerbated the neurologic deficits of AOM mice. Measures to modulate hedgehog signalling had no effect on HE neurological decline. Levels of TGF beta 1 increased in the liver and serum of mice following AOM administration. TGF beta-neutralizing antibodies slowed neurologic decline following AOM administration without significantly affecting liver damage. TGF beta 1 inhibited Gli1 expression via a SMAD3-dependent mechanism. Conversely, inhibiting TGF beta 1 increased Gli1 expression. Conclusions: Cortical activation of Gli1 protects mice from induction of HE. TGF beta 1 suppresses Gli1 in neurons via SMAD3 and promotes the neurologic decline. Strategies to activate Gli1 or inhibit TGF beta 1 signalling might be developed to treat patients with HE. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据